NPC1L1 and metabolic dysfunction-associated steatotic liver disease: Available information is limited, but a microarray transcriptomic data set from a previous study (GSE48452; human liver biopsy of different phases from control to NASH)15 may shed light on the latent link between NAFLD condition and hepatic NPC1L1‐expression levels.